Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
The Breast Journal|July 27, 2001
From adjuvant therapy to breast cancer prevention: BCPT and STARB K Dunn, L G FordHematology/Oncology Clinics of North America|January 15, 1999
Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experienceB K Dunn, B S Kramer, L G FordAnnals of Epidemiology|February 24, 2001
Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) InitiativeH A Pinto, W McCaskill-Stevens, P Wolfe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical AssociationW McCaskill-Stevens, H Pinto, A C Marcus, et al.Cancer|July 1, 1989
Therapy: state-of-the-art assessment of quality. The National Cancer Institute perspectiveL G FordAnnals of the New York Academy of Sciences|January 25, 2002
The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1)N Wolmark, B K DunnAnnals of the New York Academy of Sciences|January 25, 2002
Opportunities for future researchS Sherman, B K DunnSeminars in Oncology|June 1, 1995
Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancerG W Sledge, N Robert, J A Sparano, et al.Seminars in Oncology|October 1, 1994
Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experienceG W Sledge, N Robert, J A Sparano, et al.Annals of the New York Academy of Sciences|January 25, 2002
What would be the properties of an ideal SERM?M Anthony, J K Williams, B K DunnPageof 3